New strategies to manage the safety of cladribine in patients with multiple sclerosis

Paola Reitano; Clara G Chisari; Francesco Patti

doi:10.1080/14740338.2024.2448826

New strategies to manage the safety of cladribine in patients with multiple sclerosis

Expert Opin Drug Saf. 2025 Jan 3:1-6. doi: 10.1080/14740338.2024.2448826. Online ahead of print.

Authors

Paola Reitano^{1

2}, Clara G Chisari^{1

2}, Francesco Patti^{1

2}

Affiliations

¹ Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", University of Catania, Catania, Italy.
² UOS Multiple Sclerosis, Neurology Clinic, AOU Policlinico 'G. Rodolico-San Marco', Catania, Italy.

PMID: 39750104
DOI: 10.1080/14740338.2024.2448826

No abstract available

Keywords: Cladribine tablet; disease-modifying therapies; hepatotoxicity; immune reconstitution; infections; lymphopenia; multiple sclerosis; safety.

Publication types

Editorial